SEC Form 4 · accession 0001013606-15-000136
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vaseem Mahboob
Officer — Chief Financial Officer
Period of report
Oct 15, 2015
Accepted (ET)
Oct 16, 2015 · 1:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Oct 15, 2015 | A | 55,310 | $0.00 | A | 55,310 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase | $13.56 | Oct 15, 2015 | A | 137,024 | A | Oct 15, 2016 | Oct 15, 2025 | Common Shares | 137,024 | 137,024 | D |